SLC6A1 and epilepsy with myoclonic atonic seizures: For example, children with pathogenic SLC6A1 mutations that affect the GABA transporter 1 (GAT-1), causing high extracellular GABA levels and increased tonic inhibition in mouse models (76), present with myoclonic-atonic epilepsy and intellectual disability (77, 78).